Alimera Sciences, Inc. (NASDAQ:ALIM)
| CAPS Rating |
|
|---|
ALIM
VS S&P 500 (SPY)
ALIM News and Commentary
- Upgrades & Downgrades: More Woe for Wal-Mart – Minyanville
- PSivida: Small Cap Ophthalmology Based Biotech Positioned For Long-term Growth – Trefis
- 24/7 Wall St. Closing Bell (JNJ, KSS, WTW, DHI, LEN, TOL, ACI, ALIM, ZUMZ, ARO, ANN, CCL, FGP, HALO, – 247wallst
- 2 Stocks Stopping the Presses – The Motley Fool
- Alimera Annihilates Its Doubters – The Motley Fool
- 24/7 Wall St. Closing Bell (AAPL, NEM, DNDN, CHTR, APOL, COST, PCLN, HFC, AZO, CRZO, DPZ, ODP, SAFM, – 247wallst
- Mid-day Movers (ALIM, TBET, ODP, PEIX, CECO) – 247wallst
- Morning Movers (ALIM, TBET, ODP, PEIX, APOL) – 247wallst
- Stocks Shaking the Investment World – The Motley Fool
How do you think ALIM will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
66
Outperform
7
Underperform
All-Star Players
13
Outperform
2
Underperform
Wall Street
1
Outperform
0
Underperform
RSS Headlines
Fool UK
